
Sepehr Dehghani-Ghahnaviyeh
Articles
-
Feb 26, 2023 |
pubs.acs.org | Sepehr Dehghani-Ghahnaviyeh |Michael Smith |Michaël Smith |Yan Xia |Athanasios Dousis
AbstractLipid nanoparticles (LNPs) containing ionizable aminolipids are among the leading platforms for the successful delivery of nucleic-acid-based therapeutics, including messenger RNA (mRNA). The two recently FDA-approved COVID-19 vaccines developed by Moderna and Pfizer/BioNTech belong to this category.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →